PD 0332991
A5481003
Phase 2 small_molecule completed
Quick answer
PD 0332991 for Breast Cancer is a Phase 2 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed